Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis
Clinical trial NCT03135249 · COMPLETED
Trial details
- NCT number
- NCT03135249
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-01
- Primary completion
- 2020-11-04
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.